ANDA 75129, held by Roxane Laboratories. Albuterol Sulfate.
As of Nov 20, 2026, ANDA 75129 (Albuterol Sulfate), held by Roxane Laboratories, was first approved by FDA on Feb 13, 2001, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 13, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Albuterol SulfateEQ 0.083% BASE · solution;inhalation | Albuterol Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters